What is PharmD Live?
PharmD Live operates at the intersection of clinical pharmacy and health technology, providing a turnkey care management platform designed to optimize patient outcomes. The company specializes in medication risk management and adherence programs, which are critical components in the transition toward value-based care models. By offering services such as chronic care management, transitional care management, and annual wellness visits, PharmD Live addresses the systemic billing and clinical challenges faced by healthcare providers and Medicare/Medicaid beneficiaries alike.
The platform serves as a vital bridge for pharmaceutical companies seeking to improve medication adherence and support value-based purchasing initiatives. Through its innovative software, PharmD Live streamlines the delivery of care, reducing the administrative burden on practices while simultaneously improving the quality of life for patients managing complex health conditions. Its market position is defined by its ability to integrate seamlessly into existing clinical workflows, making it an essential partner for organizations navigating the shift from fee-for-service to outcome-oriented reimbursement structures.
How much funding has PharmD Live raised?
PharmD Live has raised a total of $1M across 1 funding round:
Angel/Seed
$1M
Angel/Seed (2022): $1M with participation from TeleDoc
Key Investors in PharmD Live
TeleDoc
A prominent leader in the telehealth and virtual care space, focusing on expanding access to remote medical services and digital health integration.
What's next for PharmD Live?
Looking ahead, the strategic deployment of this capital will likely focus on scaling the company's proprietary software architecture and expanding its network of clinical partners. As the healthcare industry continues to prioritize patient-centric, value-based care, PharmD Live is strategically positioned to capture additional market share by demonstrating measurable improvements in clinical efficacy and cost reduction. Future growth initiatives will likely involve the integration of advanced analytics to further refine medication adherence strategies and the potential expansion of its service offerings to address emerging gaps in the post-acute care sector. By maintaining its focus on high-impact, pharmacist-led interventions, the company is set to remain a key player in the digital health landscape, driving sustainable improvements in patient health outcomes and operational efficiency for its diverse client base.
See full PharmD Live company page
